|
Volumn 352, Issue 6290, 2016, Pages 1182-
|
Federal barriers to Cannabis research
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANNABIS;
MEDICAL CANNABIS;
TETRAHYDROCANNABINOL;
DRONABINOL;
CLINICAL RESEARCH;
GOVERNMENT;
HEALTH CARE COST;
HUMAN;
INTOXICATION;
LETTER;
NATIONAL HEALTH ORGANIZATION;
PRIORITY JOURNAL;
CHEMISTRY;
DRUG APPROVAL;
GOVERNMENT REGULATION;
LEGISLATION AND JURISPRUDENCE;
MEDICAL RESEARCH;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
UNITED STATES;
CANNABIS;
BIOMEDICAL RESEARCH;
CANNABIS;
DRONABINOL;
FEDERAL GOVERNMENT;
GOVERNMENT REGULATION;
HUMANS;
INVESTIGATIONAL NEW DRUG APPLICATION;
NATIONAL INSTITUTE ON DRUG ABUSE (U.S.);
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
UNITED STATES;
|
EID: 84973169052
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aaf7450 Document Type: Letter |
Times cited : (55)
|
References (8)
|